Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does CYCLOPHOSPHAMID Cause Interstitial lung disease? 6 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 6 reports of Interstitial lung disease have been filed in association with CYCLOPHOSPHAMID. This represents 20.7% of all adverse event reports for CYCLOPHOSPHAMID.

6
Reports of Interstitial lung disease with CYCLOPHOSPHAMID
20.7%
of all CYCLOPHOSPHAMID reports
1
Deaths
3
Hospitalizations

How Dangerous Is Interstitial lung disease From CYCLOPHOSPHAMID?

Of the 6 reports, 1 (16.7%) resulted in death, 3 (50.0%) required hospitalization.

Is Interstitial lung disease Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for CYCLOPHOSPHAMID. However, 6 reports have been filed with the FAERS database.

What Other Side Effects Does CYCLOPHOSPHAMID Cause?

Fatigue (5)

What Other Drugs Cause Interstitial lung disease?

METHOTREXATE (3,049) RITUXIMAB (2,458) PEMBROLIZUMAB (2,113) PREDNISONE (1,850) CYCLOPHOSPHAMIDE (1,725) NIVOLUMAB (1,538) AMIODARONE (1,421) DOXORUBICIN (1,352) ETANERCEPT (1,267) ADALIMUMAB (1,250)

Related Pages

CYCLOPHOSPHAMID Full Profile All Interstitial lung disease Reports All Drugs Causing Interstitial lung disease CYCLOPHOSPHAMID Demographics